PH25860A - Novel vaccines - Google Patents

Novel vaccines

Info

Publication number
PH25860A
PH25860A PH35427A PH35427A PH25860A PH 25860 A PH25860 A PH 25860A PH 35427 A PH35427 A PH 35427A PH 35427 A PH35427 A PH 35427A PH 25860 A PH25860 A PH 25860A
Authority
PH
Philippines
Prior art keywords
novel vaccines
vaccines
novel
Prior art date
Application number
PH35427A
Other languages
English (en)
Inventor
Anthony Arthur Holder
Michael James Lockyer
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of PH25860A publication Critical patent/PH25860A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PH35427A 1986-06-20 1987-06-19 Novel vaccines PH25860A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868615068A GB8615068D0 (en) 1986-06-20 1986-06-20 Vaccines

Publications (1)

Publication Number Publication Date
PH25860A true PH25860A (en) 1991-12-02

Family

ID=10599794

Family Applications (1)

Application Number Title Priority Date Filing Date
PH35427A PH25860A (en) 1986-06-20 1987-06-19 Novel vaccines

Country Status (12)

Country Link
EP (1) EP0250261A1 (fr)
JP (1) JPS63503512A (fr)
AU (2) AU7542287A (fr)
DK (1) DK313687A (fr)
FI (1) FI872735A (fr)
GB (1) GB8615068D0 (fr)
NO (1) NO872586L (fr)
NZ (1) NZ220777A (fr)
PH (1) PH25860A (fr)
WO (1) WO1987007908A1 (fr)
ZA (1) ZA874454B (fr)
ZW (1) ZW11387A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988002757A1 (fr) * 1986-10-17 1988-04-21 Saramane Pty. Ltd.; Polypeptides ou proteines hybrides
GB8819209D0 (en) * 1988-08-12 1988-09-14 Research Corp Ltd Polypeptide & dna encoding same
CA2037151A1 (fr) * 1990-03-23 1991-09-24 F. Hoffmann-La Roche Ag Antigene du sporozoite du plasmodium
EP1105487A1 (fr) 1998-08-21 2001-06-13 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by The Secretary, Department of Health and Human Services Vaccin anti-paludeen recombinant multivalent dirige contre plasmodium falciparum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
AU584881B2 (en) * 1984-02-21 1989-06-08 British Technology Group Limited Improvements in or relating to the production of malaria vaccines
AU606042B2 (en) * 1985-12-24 1991-01-31 Saramane Pty Ltd Asexual blood stage antigens of plasmodium falciparum

Also Published As

Publication number Publication date
AU604711B2 (en) 1991-01-03
FI872735A0 (fi) 1987-06-18
WO1987007908A1 (fr) 1987-12-30
GB8615068D0 (en) 1986-07-23
EP0250261A1 (fr) 1987-12-23
AU7542287A (en) 1988-01-12
NO872586D0 (no) 1987-06-19
DK313687A (da) 1987-12-21
ZW11387A1 (en) 1989-01-25
DK313687D0 (da) 1987-06-19
ZA874454B (en) 1989-01-25
NO872586L (no) 1987-12-21
AU7453687A (en) 1988-01-07
JPS63503512A (ja) 1988-12-22
FI872735A (fi) 1987-12-21
NZ220777A (en) 1990-12-21

Similar Documents

Publication Publication Date Title
EP0256878A3 (en) Vaccines
ZA88149B (en) Anti-reproductive vaccines
GB8702691D0 (en) Vaccines
PH23573A (en) Novel dialkylmaleimides
ZA872532B (en) Combined vaccine
ZW22487A1 (en) Vaccine
EP0257859A3 (en) Novel combination
ZA874847B (en) Oncornavirus vaccines
ZA876543B (en) Novel 4-methylphthalimides
PH25860A (en) Novel vaccines
GB8704647D0 (en) Vaccine
GB8607072D0 (en) Retaining means
IL84818A0 (en) Novel dihydrothiadiazoles
GB8605646D0 (en) Vaccines
GB2198131B (en) Novel prostacyclines
GB8606559D0 (en) Vaccines
GB8629988D0 (en) Vaccines
GB8606560D0 (en) Vaccines
GB8629475D0 (en) Vaccines
GB8604743D0 (en) Vaccines
GB8620059D0 (en) Vaccines
IE860761L (en) Non-adjuvenated vaccine
IE860337L (en) Vaccine
GB8619602D0 (en) Vaccine
GB8609011D0 (en) Retaining means